Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Trials

ABSTRACT Background The cardioprotective effects of glucagon‐like peptide‐1 receptor agonist (GLP‐1RA)‐based therapies in nondiabetic individuals with overweight or obesity remain underexplored. This meta‐analysis evaluates their impact on cardiovascular events and metabolic parameters in this popul...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yue Yin, Minghan Zhang, Qiuyu Cao, Lin Lin, Jieli Lu, Yufang Bi, Yuhong Chen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2025-04-01
Ráidu:	Journal of Diabetes
Fáttát:	cardiometabolic cardiovascular disease GLP‐1 receptor agonist‐based therapies GLP‐1RAs meta‐analysis obesity or overweight
Liŋkkat:	https://doi.org/10.1111/1753-0407.70082
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!